Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Organogenesis Holdings Inc. Class A Common Stock (ORGO)
Organogenesis Holdings Inc. Class A Common Stock
XNAS:ORGO
5.06
-6.64%

Ask
$5.91 - 100.00
Bid
$4.62 - 100.00
Low
$5.11
High
$5.43
Open
$5.36
Prev Close
$5.42
52W High
7.08
52W Low
2.61
Volume
434346
Avg Vol (3m)
1539185.8
Float
58831199.81
Chart
TendieTensor AI Analysis

Company
Asset Type: Common Stock
SIC Code: 2834
Sector: Health Technology
Industry: Medical Specialties
Date Listed: 11/29/2016
Primary Exchange: XNAS

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Phone: 781-575-0775
Address: 85 Dan Road
City: Canton
State: MA
Postal Code: 02021
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
869
P/E (TTM)
-52.800000
P/B (TTM)
2.576760
EPS
0.15
Round Lot
100
Composit FIGI
BBG00FGGD295
Share Class FIGI
BBG00FGGD311
Share Class Shares Outstanding
126.86M
Weighted Shares Outstanding
126.91M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own ORGO. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.